Coronary artery disease Medical Services in China

Coronary artery disease (CAD), commonly known as coronary heart disease, is a chronic condition characterized by the narrowing or blockage of the coronary arteries—typically due to atherosclerotic plaque buildup—leading to myocardial ischemia, angina pectoris, acute coronary syndromes, and potentially myocardial infarction. Risk factors include hypertension, dyslipidemia, diabetes mellitus, smoking, obesity, and sedentary lifestyle. Diagnosis relies on clinical evaluation, electrocardiography, stress testing, coronary angiography, and increasingly, non-invasive coronary computed tomography angiography (CCTA) and intravascular ultrasound (IVUS). Management encompasses pharmacotherapy (antiplatelets, statins, beta-blockers, ACE inhibitors), lifestyle modification, percutaneous coronary intervention (PCI) with drug-eluting stents, and coronary artery bypass grafting (CABG) for complex multivessel disease.

China offers compelling advantages for CAD treatment: its tier-1 cardiovascular centers—such as Fuwai Hospital (National Center for Cardiovascular Diseases) and Shanghai Ruijin Hospital—rank among Asia’s most advanced, with internationally trained interventional cardiologists performing over 100,000 PCI procedures annually. State-of-the-art hybrid operating rooms, robotic-assisted PCI platforms, and real-time fractional flow reserve (FFR) guidance ensure precision and safety. Five-year survival rates for high-risk CABG patients exceed 85%, supported by robust clinical registries and outcomes tracking. Crucially, costs for comprehensive CAD care—including diagnostics, stenting, or bypass surgery—are typically 40–60% lower than in the US or Western Europe, without compromising evidence-based protocols or accreditation standards (JCI- or CNAS-certified facilities).

As a dedicated medical tourism agency, we facilitate seamless access to these resources for international patients: verifying physician credentials, coordinating appointments at vetted hospitals, providing itemized, transparent pricing in advance, arranging visa support, medical translation, accommodation, and post-procedure follow-up—all under one coordinated service framework.

China offers a compelling option for coronary artery disease treatment, combining advanced medical capabilities with significant cost advantages. Patients typically save 40–60% compared to the U.S. or Western Europe—for example, a comprehensive coronary intervention package, including diagnostics, stenting, and post-procedure care, averages $8,000–$12,000 in top-tier Chinese hospitals versus $25,000–$45,000 in the U.S. Leading cardiovascular centers in Beijing, Shanghai, and Guangzhou utilize state-of-the-art equipment—including intravascular ultrasound (IVUS), optical coherence tomography (OCT), and robotic-assisted PCI—and maintain high-volume experience, performing over 100,000 cardiac interventions annually across major institutions. Many cardiologists hold international training and publish in peer-reviewed journals, ensuring evidence-based, protocol-driven care. Our agency supports patients with transparent, all-inclusive pricing—no hidden fees—and assists in selecting JCI-accredited or nationally certified hospitals aligned with clinical needs and budget. We coordinate pre-arrival assessments, streamline visa and travel logistics, and provide dedicated bilingual case managers throughout treatment and recovery. Appointments are typically scheduled within 7–10 days, and follow-up consultations can be arranged remotely. This integrated approach balances clinical excellence, affordability, and logistical efficiency for international patients seeking reliable coronary care.

International Patient Treatment Process for Coronary Heart Disease (Cardiology): After initial inquiry, our agency coordinates a remote consultation with a certified cardiologist to review medical records and determine treatment feasibility. Required materials include recent ECGs, echocardiograms, coronary angiography reports, blood test results, and physician referrals—all translated into English if necessary. We schedule all in-person appointments (outpatient evaluation, diagnostic tests, procedure, follow-up) within 5–7 business days of document submission. Our team provides certified medical translators during all clinical interactions and accompanies patients to appointments. We arrange hotel accommodations near the hospital, assist with visa documentation support, and coordinate airport transfers. Treatment—whether medication optimization, PCI, or CABG—is conducted per international guidelines, with post-procedure monitoring and discharge planning. The full process typically takes 10–21 days, depending on diagnostic findings and procedure type. All communications are available in English, Mandarin, Arabic, Russian, and Spanish; dedicated case managers remain accessible 24/7 via phone or secure messaging. Upon completion, we provide translated discharge summaries, prescriptions, and follow-up care instructions. No additional fees apply for translation, accompaniment, or accommodation coordination services.

Medical Travel to China Guide: Coronary Heart Disease (Cardiology)

Visa & Entry: Most nationalities require a Chinese visa; our team assists with invitation letters from partner hospitals and guides you through the application. A valid passport and proof of medical purpose are essential.

Medical Insurance & Payment: International health insurance may cover part of treatment—verify coverage with your provider. We offer transparent, all-inclusive pricing upfront (consultation, diagnostics, procedure, hospital stay), with no hidden fees. Our agency facilitates secure payments in USD/EUR via bank transfer or credit card, and helps coordinate insurance pre-authorization where applicable.

Accommodation & Companions: We arrange comfortable, hospital-proximate hotels (single/double rooms) and assist with visa support for one companion. Airport transfers and local transport are included.

Follow-Up Care: Post-treatment, we schedule virtual consultations with your cardiologist, share digital medical records, and coordinate with your home physician for seamless continuity of care—including medication guidance and lifestyle recommendations. Our dedicated care coordinator remains available for 90 days post-return to address questions or arrange remote ECG/echo reviews.